Table 8 Probabilistic Sensitivity Analysis
Second-line agent add-on to Metformin | Average Total | Average Incremental | |||
|---|---|---|---|---|---|
Costs | Life Years Gained | Costs | Life Years Gained | ICER | |
Sulfonylurea | $7004 (±316.52) | 11.93 (±0.07) |  |  |  |
Dipeptidyl peptidase-4 inhibitor | $18790 (±1008.70) | 12.52 (±0.07) | $ 11786 (±976.92) | 0.59 (±0.02) | $19980 |